Key result
Levothyroxine treatment in patients with subclinical hypothyroidism reduced arterial stiffness, decreasing the augmentation index from 17.2 to 14.3.
Why the study?
Does levothyroxine improve arterial stiffness and lipid profile in patients with subclinical hypothyroidism?
Observational (n=30)
Does levothyroxine improve arterial stiffness and lipid profile in patients with subclinical hypothyroidism?
Answers are grounded in this paper and cite their sources.
Levothyroxine treatment in patients with subclinical hypothyroidism significantly improves arterial stiffness and systolic blood pressure, but does not significantly alter lipid profile or inflammation.
BACKGROUND: The influence of treatment for subclinical hypothyroidism (SCH) on cardiovascular morbidity and mortality, arterial stiffness, and lipid profile has not been elucidated yet. The aim of this study was to evaluate the effect of levothyroxine on arterial stiffness, lipid profile, and inflammation. METHODS: The study included 30 patients with SCH. Patients were treated with levothyroxine and were assessed at baseline and at 1, 4, and 7 months. Blood samples were taken for lipid profile and highly sensitive C-reactive protein (hs-CRP). Arterial stiffness was evaluated by augmentation index (AIx). In conditions that cause arterial stiffness, the pulse wave traveling from the periphery to the heart reaches the heart during systole, resulting in augmentation of the central pressure. This increase, calculated as the AIx, is a good expression of central aortic pressure. RESULTS: After accomplishing euthyroidism, the AIx decreased from 17.2 +/- 8.3 to 14.3 +/- 6.5 (p < 0.01) and AIx percentage decreased from 36.2 +/- 11.5 to 33.2 +/- 9.1 (p = 0.03). Systolic blood pressure (SBP) decreased from 134.7 +/- 20 to 127.6 +/- 13.7 mmHg (p < 0.01). In those patients whose AIx decreased, low-density lipoprotein (LDL) levels decreased by 0.4 +/- 0.96 mmol/L compared to the patients whose AIx did not decrease and LDL increased by 0.62 +/- 1.48 mmol/L (p = 0.057). Total cholesterol decreased by 0.72 +/- 1.64 mmol/L in the patients whose AIx decreased and increased by 1 +/- 2.53 mg/dL in the patients whose AIx did not improve (p = 0.06). CONCLUSIONS: In patients with SCH, treatment with levothyroxine had a significant beneficial effect on arterial stiffness and SBP, and no effect on lipid profile or hs-CRP.
No takes yet. Share an insight, caveat, or question.
Peleg et al. (2008) conducted an observational in Subclinical hypothyroidism (n=30). Levothyroxine vs. Baseline was evaluated on Augmentation index (AIx) (p=<0.01). Levothyroxine treatment in patients with subclinical hypothyroidism reduced arterial stiffness, decreasing the augmentation index from 17.2 to 14.3.
Synapse has enriched 10 related papers. Consider them for comparative context: